These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
437 related items for PubMed ID: 29560563
1. Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis. Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A. Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563 [Abstract] [Full Text] [Related]
2. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis. Lu Y, Grant C, Xie K, Sweiss NJ. Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863 [Abstract] [Full Text] [Related]
3. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis. Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC. JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396 [Abstract] [Full Text] [Related]
13. Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia. Muser D, Santangeli P, Castro SA, Liang JJ, Enriquez A, Werner TJ, Nucifora G, Magnani S, Hayashi T, Zado ES, Garcia FC, Callans DJ, Dixit S, Desjardins B, Marchlinski FE, Alavi A. Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956 [Abstract] [Full Text] [Related]
14. 18F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan. Chauvelot P, Skanjeti A, Jamilloux Y, de Parisot A, Broussolle C, Denis P, Ramackers JM, Giammarile F, Kodjikian L, Seve P. Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987 [Abstract] [Full Text] [Related]
16. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis. Sperry BW, Tamarappoo BK, Oldan JD, Javed O, Culver DA, Brunken R, Cerqueira MD, Hachamovitch R. JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747 [Abstract] [Full Text] [Related]
17. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet. Kobayashi Y, Kumita S, Fukushima Y, Ishihara K, Suda M, Sakurai M. J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066 [Abstract] [Full Text] [Related]
18. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis. Manabe O, Yoshinaga K, Ohira H, Sato T, Tsujino I, Yamada A, Oyama-Manabe N, Masuda A, Magota K, Nishimura M, Tamaki N. Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126 [Abstract] [Full Text] [Related]